These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 6437758)

  • 1. The relationship between the level of lipidemia and the macrovascular complications of diabetes.
    Hu SX; Pan XR; Huang PL; Lin JS; Wen QC; Chi ZS
    Chin Med J (Engl); 1984 Jun; 97(6):405-10. PubMed ID: 6437758
    [No Abstract]   [Full Text] [Related]  

  • 2. [Correlation between serum lipids, thrombocyte function and angiopathies in diabetes mellitus].
    Duţu A; Gligore V; Hîncu N; Poduţ A; Tecuceanu R
    Med Interna (Bucur); 1972 Jan; 24(1):81-8. PubMed ID: 5021765
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperlipidaemias and vascular complications of diabetes mellitus.
    Suri RK; Gupta MM; Chakravarti AK
    J Assoc Physicians India; 1979 Jun; 27(6):505-10. PubMed ID: 528508
    [No Abstract]   [Full Text] [Related]  

  • 4. The prevalence of hyperlipidemia in patients with advanced peripheral arterial disease.
    Battaglini J; Picket R; Barefoot S; Johnson G; Gwynn J
    Curr Surg; 1980; 37(4):291-3. PubMed ID: 7398368
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fish oil as lipostatic factor].
    Fasching P; Ratheiser K; Waldhäusl W; Rohac M; Vierhapper H
    Vasa Suppl; 1990; 30():62-3. PubMed ID: 2075591
    [No Abstract]   [Full Text] [Related]  

  • 6. Factors influencing the progress of atherosclerosis in the diabetic.
    Keen H
    Acta Diabetol Lat; 1971 Sep; 8 Suppl 1():444-62. PubMed ID: 5146918
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk factors for macrovascular disease in type 2 diabetes. Classic lipid abnormalities.
    Steiner G
    Diabetes Care; 1999 Apr; 22 Suppl 3():C6-9. PubMed ID: 10189556
    [No Abstract]   [Full Text] [Related]  

  • 8. [Postheparinic lipolytic activity in diabetes].
    Plamieniak L
    Pol Tyg Lek; 1974 Jul; 29(28):1197-200. PubMed ID: 4846887
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum sialic acid and carbohydrate-deficient transferrin concentration in Type 2 diabetes mellitus with and without macrovascular complications.
    Chrostek L; Cylwik B; Poplawska A; Szmitkowski M; Koput A
    Diabetes Nutr Metab; 2004 Dec; 17(6):371-3. PubMed ID: 15887632
    [No Abstract]   [Full Text] [Related]  

  • 10. [Plasma, erythrocyte and platelet magnesium in essential hyperTension, diabetes mellitus without and with macrovascular complications and atherosclerotic vascular disease].
    Grifò G; Lo Presti R; Montana M; Canino B; Caimi G
    Recenti Prog Med; 1995 Nov; 86(11):431-6. PubMed ID: 8539474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lipids disorder, macrovascular diseases, and insulin resistance in Chinese diabetic patients].
    Xu ZR; Wang YZ; Jing H; Liu YJ; Huang LJ; Wu CR; Yang WS; Yang JD; Song W; Wang AH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Oct; 24(5):457-61. PubMed ID: 12905764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Content of intermediate products of carbohydrate and lipid metabolism in the venous blood in diabetic angiopathies].
    Vaniurikhina LT; Timchenko IG; Lapko LI
    Vrach Delo; 1982 Aug; (8):30-1. PubMed ID: 7147873
    [No Abstract]   [Full Text] [Related]  

  • 13. Diabetes and atherosclerosis in the Pima Indians.
    Howard BV; Lisse JR; Knowler WC; Davis MP; Pettitt DJ; Bennett PH
    Mt Sinai J Med; 1982; 49(3):169-75. PubMed ID: 6750365
    [No Abstract]   [Full Text] [Related]  

  • 14. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2.
    de Luis DA; Fernandez N; Arranz ML; Aller R; Izaola O; Romero E
    J Diabetes Complications; 2005; 19(1):42-6. PubMed ID: 15642489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of hyperlipidemia in diabetes.
    Vinik AI; O'Brian JT; Georges LP; Leichter SB; Janin Y
    Compr Ther; 1995 Oct; 21(10):602-9. PubMed ID: 8565431
    [No Abstract]   [Full Text] [Related]  

  • 16. [A nationwide retrospective analysis on chronic diabetic complications and related macrovascular diseases of in-patients with diabetes during 1991-2000].
    ;
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Oct; 24(5):447-51. PubMed ID: 12905762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of serum high sensitivity C-reactive protein to metabolic syndrome and microvascular complications in type 2 diabetes.
    Kang ES; Kim HJ; Ahn CW; Park CW; Cha BS; Lim SK; Kim KR; Lee HC
    Diabetes Res Clin Pract; 2005 Aug; 69(2):151-9. PubMed ID: 16005364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnitude of dyslipedemia and its association with micro and macro vascular complications in type 2 diabetes: a hospital based study from Bikaner (Northwest India).
    Agrawal RP; Sharma P; Pal M; Kochar A; Kochar DK
    Diabetes Res Clin Pract; 2006 Aug; 73(2):211-4. PubMed ID: 16580758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoproteins as risk factors for vascular disease in diabetes.
    Brown WV; Bloomgarden Z; Ginsberg H
    Mt Sinai J Med; 1982; 49(3):176-86. PubMed ID: 6981757
    [No Abstract]   [Full Text] [Related]  

  • 20. Sialic Acid, possible marker of angiopathic complications at diabetics type 2.
    Faur L; Motocu M; Moldovan C; Onaca M; Muţiu G
    Rom J Morphol Embryol; 2005; 46(4):307-9. PubMed ID: 16688368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.